Search research articles
Contact Us
Filters
Showing results (161-170 of 270) with videos related to
Page
of 27
Sort By:
Frontiers in Oncology
|
November 16, 2020
Multi-Lineage <i>BCR-ABL</i> Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features
Satoshi Nishiwaki, Jeong Hui Kim, Masafumi Ito, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2025
Development and optimization of Eva1 (<i>MPZL2</i>) targeting chimeric antigen receptor T cells
Masahide Osaki, Seitaro Terakura, Shiho Hirano, et al.
Thrombosis Research
|
March 4, 2020
Higher FVIII:C measured by chromogenic substrate assay than by one-stage assay is associated with silent hemophilic arthropathy
Mika Ogawa, Nobuaki Suzuki, Nobunori Takahashi, et al.
Cancer Science
|
November 7, 2022
Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene
Koya Odaira, Takahiko Yasuda, Kentaro Okada, et al.
Cancer Science
|
May 19, 2011
Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study
Noriko Usui, Akihiro Takeshita, Chiaki Nakaseko, et al.
Cancer Science
|
July 9, 2010
Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: a report from the BINGO study
Yuichi Ishikawa, Hitoshi Kiyoi, Keisuke Watanabe, et al.
British Journal of Haematology
|
April 10, 2008
Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome
Tomohiko Sato, Tsutomu Toki, Rika Kanezaki, et al.
Cancer Science
|
November 21, 2024
Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O
Fumihiko Hayakawa, Naoki Mori, Kiyotoshi Imai, et al.
Asia-Pacific Journal of Clinical Oncology
|
June 29, 2021
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Yukio Kobayashi, Iekuni Oh, Toshihiro Miyamoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 8, 2026
Antithrombotic Therapy on Antithrombin Resistance in a Mouse Model
Nobuaki Suzuki, Atsuo Suzuki, Shogo Tamura, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 270) with videos related to
Sort By:
Page
of 27
Frontiers in Oncology
|
November 16, 2020
Multi-Lineage <i>BCR-ABL</i> Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features
Satoshi Nishiwaki, Jeong Hui Kim, Masafumi Ito, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2025
Development and optimization of Eva1 (<i>MPZL2</i>) targeting chimeric antigen receptor T cells
Masahide Osaki, Seitaro Terakura, Shiho Hirano, et al.
Thrombosis Research
|
March 4, 2020
Higher FVIII:C measured by chromogenic substrate assay than by one-stage assay is associated with silent hemophilic arthropathy
Mika Ogawa, Nobuaki Suzuki, Nobunori Takahashi, et al.
Cancer Science
|
November 7, 2022
Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene
Koya Odaira, Takahiko Yasuda, Kentaro Okada, et al.
Cancer Science
|
May 19, 2011
Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study
Noriko Usui, Akihiro Takeshita, Chiaki Nakaseko, et al.
Cancer Science
|
July 9, 2010
Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: a report from the BINGO study
Yuichi Ishikawa, Hitoshi Kiyoi, Keisuke Watanabe, et al.
British Journal of Haematology
|
April 10, 2008
Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome
Tomohiko Sato, Tsutomu Toki, Rika Kanezaki, et al.
Cancer Science
|
November 21, 2024
Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O
Fumihiko Hayakawa, Naoki Mori, Kiyotoshi Imai, et al.
Asia-Pacific Journal of Clinical Oncology
|
June 29, 2021
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Yukio Kobayashi, Iekuni Oh, Toshihiro Miyamoto, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 8, 2026
Antithrombotic Therapy on Antithrombin Resistance in a Mouse Model
Nobuaki Suzuki, Atsuo Suzuki, Shogo Tamura, et al.
Page
of 27